If the ambs shareholder population is actually expecting revenue in three months, then the pps will go DOWN to three cents.
In order for that to happen, the specific protocols would have been identified, the approval would have come before that, and so many things would have to have happened, none of which have happened yet.
In other news, the principal investigator along with LOTS of other standard milestones have NOT been announced and it is mid October, an Eltoprazine study this year or even in the first quarter is difficult to predict.
Once again, GC is over promising because he needs the currency. His actions could NOT reflect a more incompetent CEO.
Nothing hurts more than dashed hopes. In this case, hopes have been dashed so many times, I've lost track.
News 
Market Data 
Discover 
AI
